These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24440282)

  • 21. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Papillomavirus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer.
    Labarge B; Hennessy M; Zhang L; Goldrich D; Chartrand S; Purnell C; Wright S; Goldenberg D; Broach JR
    Mol Cancer Res; 2022 Sep; 20(9):1420-1428. PubMed ID: 35657601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
    Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
    Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014.
    Carlander AF; Grønhøj Larsen C; Jensen DH; Garnæs E; Kiss K; Andersen L; Olsen CH; Franzmann M; Høgdall E; Kjær SK; Norrild B; Specht L; Andersen E; van Overeem Hansen T; Nielsen FC; von Buchwald C
    Eur J Cancer; 2017 Jan; 70():75-82. PubMed ID: 27888679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.
    Rietbergen MM; Leemans CR; Bloemena E; Heideman DA; Braakhuis BJ; Hesselink AT; Witte BI; Baatenburg de Jong RJ; Meijer CJ; Snijders PJ; Brakenhoff RH
    Int J Cancer; 2013 Apr; 132(7):1565-71. PubMed ID: 22949073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, Clinicopathological Characteristics, and Outcome of Human Papillomavirus-Associated Oropharyngeal Cancer in Southern Chinese Patients.
    Lam EW; Chan JY; Chan AB; Ng CS; Lo ST; Lam VS; Chan MM; Ngai CM; Vlantis AC; Ma RK; Chan PK
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):165-73. PubMed ID: 26604268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
    Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.
    Miller DL; Davis JW; Taylor KH; Johnson J; Shi Z; Williams R; Atasoy U; Lewis JS; Stack MS
    Am J Pathol; 2015 Mar; 185(3):679-92. PubMed ID: 25572154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression.
    Olthof NC; Speel EJ; Kolligs J; Haesevoets A; Henfling M; Ramaekers FC; Preuss SF; Drebber U; Wieland U; Silling S; Lam WL; Vucic EA; Kremer B; Klussmann JP; Huebbers CU
    PLoS One; 2014; 9(2):e88718. PubMed ID: 24586376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical, radiological and morphological features including the distribution of HPV E6/E7 oncogenes in resection specimens of oropharyngeal squamous cell carcinoma.
    Channir HI; Kiss K; Rubek N; Andersen J; Georgsen JB; Rathje GS; Charabi BW; von Buchwald C; Lajer CB
    Oral Oncol; 2018 Mar; 78():163-170. PubMed ID: 29496046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and characteristics of HPV infection in oropharyngeal cancer.
    De Stefani A; Boffano P; Averono G; Ramella A; Pia F; Bongioannini G
    J Craniofac Surg; 2013 Jan; 24(1):e40-3. PubMed ID: 23348332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors.
    Thorland EC; Myers SL; Gostout BS; Smith DI
    Oncogene; 2003 Feb; 22(8):1225-37. PubMed ID: 12606949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
    Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV+ oropharyngeal squamous cell carcinomas from patients with two tumors display synchrony of viral genomes yet discordant mutational profiles and signatures.
    Faden DL; Langenbucher A; Kuhs K; Lewis JS; Mirabello L; Yeager M; Boland JF; Bass S; Steinberg M; Cullen M; Lawrence MS; Ferris RL
    Carcinogenesis; 2021 Feb; 42(1):14-20. PubMed ID: 33075810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
    Anayannis NV; Schlecht NF; Belbin TJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Papillomavirus 16 Physical Status and the TP53 Codon 72 Polymorphism in Japanese HPV-Positive Oropharyngeal Cancer Patients.
    Saito Y; Ando M; Fujimoto C; Omura G; Kobayashi K; Asakage T; Yamasoba T
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(1):46-54. PubMed ID: 26785263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
    Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.